1. Home
  2. TV vs NUVB Comparison

TV vs NUVB Comparison

Compare TV & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Televisa S.A.

TV

Grupo Televisa S.A.

HOLD

Current Price

$2.69

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$6.53

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TV
NUVB
Founded
1969
2018
Country
Mexico
United States
Employees
26599
307
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TV
NUVB
Price
$2.69
$6.53
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$5.30
$11.38
AVG Volume (30 Days)
1.0M
4.3M
Earning Date
05-12-2026
05-04-2026
Dividend Yield
2.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$203.82
Revenue Next Year
N/A
$58.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$1.87
52 Week High
$3.49
$9.75

Technical Indicators

Market Signals
Indicator
TV
NUVB
Relative Strength Index (RSI) 41.88 77.02
Support Level $2.61 $4.13
Resistance Level $2.95 $8.95
Average True Range (ATR) 0.11 0.41
MACD -0.00 0.16
Stochastic Oscillator 22.45 98.87

Price Performance

Historical Comparison
TV
NUVB

About TV Grupo Televisa S.A.

Televisa is one of the leading telecom firms in Mexico. Its cable arm, Izzi, holds networks that pass 20 million Mexican homes and provide broadband service to nearly 6 million customers. The firm is also one of the largest pay-television providers in Mexico, with nearly 4 million customers. Televisa owns Sky Mexico, the country's only satellite-TV provider, serving about 4 million customers. After merging its traditional media business into Univision, Grupo Televisa owns a 43% stake in the combined entity TelevisaUnivision. Grupo Televisa spun off several smaller businesses, including magazine publishing, three of Mexico's professional soccer teams, and Azteca Stadium in February 2024, under the name Ollamani.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: